Your browser doesn't support javascript.
SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer
Rugge, Massimo; Zorzi, Manuel; Guzzinati, Stefano.
  • Rugge, Massimo; Department of Medicine. Padova. Italy
  • Zorzi, Manuel; Veneto Tumor Registry (RTV). Azienda Zero. Italy
  • Guzzinati, Stefano; Veneto Tumor Registry (RTV). Azienda Zero. Italy
Nature Cancer ; 2020.
Article in English | ELSEVIER | ID: covidwho-691527
ABSTRACT
In 84,246 consecutive Italians tested for SARS-CoV-2, we examined the prevalence of cancer and clinical outcomes of viral infection. Overall, 5.7% (4,789/84,246) had previously been diagnosed with cancer and, among the SARS-CoV-2-positive (CV2+ve) patients, 7.8% had a cancer diagnosis (723/9,275). Prevalence of cancer was not associated with risk of infection (odds ratio of 0.97; 95% confidence interval of 0.89–1.06). The proportion of CV2+ve people hospitalized was higher among patients with cancer (56.6 versus 34.4% among other people), and so was the proportion of deaths (14.7% versus 4.5%). The risk of adverse outcomes of SARS-CoV-2 infection was significantly higher for patients with cancer versus those without, particularly for males and older people.

Full text: Available Collection: International databases Database: ELSEVIER Document Type: Article Type of study: Risk factors Language: English Journal: Nature Cancer Year: 2020

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: ELSEVIER Document Type: Article Type of study: Risk factors Language: English Journal: Nature Cancer Year: 2020
...